BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37668524)

  • 1. Development of a Semiquantitative Whole-Body MRI Scoring System for Multiple Myeloma.
    Kim DK; Jung JY; Kim H; Lee S; Lee SY; Lee S; Park SS; Min CK
    Radiology; 2023 Sep; 308(3):e230667. PubMed ID: 37668524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
    Dutoit JC; Vanderkerken MA; Verstraete KL
    Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma.
    Lai AYT; Riddell A; Barwick T; Boyd K; Rockall A; Kaiser M; Koh DM; Saffar H; Yusuf S; Messiou C
    Eur Radiol; 2020 Jan; 30(1):320-327. PubMed ID: 31267214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance.
    Dong H; Huang W; Ji X; Huang L; Zou D; Hao M; Deng S; Shen Z; Lu X; Wang J; Song Z; Zhang X; Xue H; Xia S
    AJR Am J Roentgenol; 2022 Feb; 218(2):310-319. PubMed ID: 34523949
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of Whole-Body DWI and
    Chen J; Li C; Tian Y; Xiao Q; Deng M; Hu H; Wen B; He Y
    AJR Am J Roentgenol; 2019 Sep; 213(3):514-523. PubMed ID: 31166755
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of a whole spinal MRI-based tumor burden scoring method in participants with multiple myeloma: a pilot study of prognostic significance.
    Cui S; Guo Y; Li J; Bian W; Wu W; Zhang W; Zheng Q; Guan H; Wang J; Niu J
    Ann Hematol; 2024 May; 103(5):1665-1673. PubMed ID: 38326481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
    D'Anastasi M; Notohamiprodjo M; Schmidt GP; Dürr HR; Reiser MF; Baur-Melnyk A
    AJR Am J Roentgenol; 2014 Oct; 203(4):854-62. PubMed ID: 25247952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
    Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G
    Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histogram Analysis Based on Apparent Diffusion Coefficient Maps of Bone Marrow in Multiple Myeloma: An Independent Predictor for High-risk Patients Classified by the Revised International Staging System.
    Wang Q; Zhang L; Li S; Sun Z; Wu X; Zhao A; Benkert T; Zhou D; Xue H; Jin Z; Li J
    Acad Radiol; 2022 Jun; 29(6):e98-e107. PubMed ID: 34452820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response.
    Park HY; Kim KW; Yoon MA; Lee MH; Chae EJ; Lee JH; Chung HW; Yoon DH
    Cancer Imaging; 2020 Jan; 20(1):14. PubMed ID: 32000858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D; Patti C; Lagalla R; Midiri M; Galia M
    J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of whole-body 64-slice multidetector computed tomography in treatment planning for multiple myeloma.
    Razek AA; Ezzat A; Azmy E; Tharwat N
    Radiol Med; 2013 Aug; 118(5):799-805. PubMed ID: 22986700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease.
    Wolf MB; Murray F; Kilk K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
    Eur J Radiol; 2014 Jul; 83(7):1222-1230. PubMed ID: 24793843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-observer agreement of baseline whole body MRI in multiple myeloma.
    Croft J; Riddell A; Koh DM; Downey K; Blackledge M; Usher M; Boyd K; Kaiser M; Messiou C
    Cancer Imaging; 2020 Jul; 20(1):48. PubMed ID: 32665028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor load in patients with multiple myeloma: β₂-microglobulin levels versus low-dose whole-body CT.
    Pfahler V; D'Anastasi M; Dürr HR; Schinner R; Ricke J; Baur-Melnyk A
    Eur J Haematol; 2020 May; 104(5):383-389. PubMed ID: 31762076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quantitative parameters based on marrow metabolism derived from synthetic MRI: A pilot study of prognostic value in participants with newly diagnosed multiple myeloma.
    Cui S; Guo Y; Niu W; Li J; Bian W; Wu W; Zhang W; Zheng Q; Wang J; Niu J
    Cancer Med; 2024 Apr; 13(7):e7109. PubMed ID: 38553942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid simultaneous whole-body 2-[
    Jamet B; Carlier T; Bailly C; Bodet-Milin C; Monnet A; Frampas E; Touzeau C; Moreau P; Kraeber-Bodere F
    Eur Radiol; 2023 Sep; 33(9):6438-6447. PubMed ID: 37022439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pictorial review of whole body MRI in myeloma: emphasis on diffusion-weighted imaging.
    Hameed M; Sandhu A; Soneji N; Amiras D; Rockall A; Messiou C; Wallitt K; Barwick TD
    Br J Radiol; 2020 Nov; 93(1115):20200312. PubMed ID: 32667830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI.
    Takasu M; Kondo S; Akiyama Y; Takahashi Y; Maeda S; Baba Y; Kawase T; Ichinohe T; Awai K
    PLoS One; 2020; 15(2):e0229607. PubMed ID: 32106239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeatability and test-retest reproducibility of mean apparent diffusion coefficient measurements of focal and diffuse disease in relapsed multiple myeloma at 3T whole body diffusion-weighted MRI (WB-DW-MRI).
    ElGendy K; Barwick TD; Auner HW; Chaidos A; Wallitt K; Sergot A; Rockall A
    Br J Radiol; 2022 Sep; 95(1138):20220418. PubMed ID: 35867890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.